Iggenix, Inc.
Overview
Iggenix, Inc. is a biotechnology company focused on developing innovative therapeutic antibodies for the treatment of severe allergic diseases. Leveraging its novel proprietary technology platform, Iggenix aims to transform the therapeutic paradigm for allergy management.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Iggenix, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.